Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Mutagenic DNA Lesions in Normal Hematopoietic Stem Cells Persist for Years Causing Distinct Patterns of Mutation

Blood (2024) 144 (Supplement 1): 2673.

https://doi.org/10.1182/blood-2024-208773

Published: 2024

Journal Articles

Pervasive Positive Selection in Blood in 200,618 Individuals and Novel Drivers of Clonal Hematopoiesis

Nicholas Bernstein, Michael Spencer Chapman, Kudzai Nyamondo, Zhenghao Chen, Nicholas Williams, Emily Mitchell, Peter Campbell, Robert L Cohen, Jyoti Nangalia

Blood (2023) 142 (Supplement 1): 4062.

https://doi.org/10.1182/blood-2023-185188

Published: 2023

Journal Articles

Minimal Residual Disease Eradication with Venetoclax in Acute Myeloid Leukemia

Alexander Coltoff, MD, Joseph G. Jurcic, MD, Peter Campbell, PharmD, BCOP, Daniel J. Lee, MD, Mark L Heaney, MD, Nicole Lamanna, MD, Todd L. Rosenblat, MD MS, Mark G. Frattini, MDPhD, George Vlad, PhD

Blood (2020) 136 (Supplement 1): 12–14.

https://doi.org/10.1182/blood-2020-134237

Published: 2020

Journal Articles

Cohesin-dependent regulation of gene expression during differentiation is lost in cohesin-mutated myeloid malignancies

Daniel Sasca, Haiyang Yun, George Giotopoulos, Jakub Szybinski, Theo Evan, Nicola K. Wilson, Moritz Gerstung, Paolo Gallipoli, Anthony R. Green, Robert Hills, Nigel Russell, Cameron S. Osborne, Elli Papaemmanuil, Berthold Göttgens, Peter Campbell, Brian J. P. Huntly

Blood (2019) 134 (24): 2195–2208.

https://doi.org/10.1182/blood.2019001553

Published: 2019

Includes: Supplemental data

Journal Articles

A Knowledge-Based Approach for Clinical Annotation of Oncogenic Variants to Support Patient-Tailored Diagnosis in Myeloid Disease

Blood (2017) 130 (Supplement 1): 1414.

https://doi.org/10.1182/blood.V130.Suppl_1.1414.1414

Published: 2017

Journal Articles

Analysis of Mutational Signatures Suggest That Aid Has an Early and Driver Role in Multiple Myeloma

Blood (2016) 128 (22): 116.

https://doi.org/10.1182/blood.V128.22.116.116

Published: 2016

Journal Articles

Whole Genome Sequencing of Unique Paired SMM/MGUS Progressing to MM Samples Reveals a Genomic Landscape with Diverse Evolutionary Pattern

Blood (2016) 128 (22): 2088.

https://doi.org/10.1182/blood.V128.22.2088.2088

Published: 2016

Journal Articles

GATA1 -mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia

Blood (2013) 122 (24): 3908–3917.

https://doi.org/10.1182/blood-2013-07-515148

Published: 2013

Includes: Supplemental data

Journal Articles

Aberrant 3′ oligoadenylation of spliceosomal U6 small nuclear RNA in poikiloderma with neutropenia

Christine Hilcenko, Paul J. Simpson, Andrew J. Finch, Frank R. Bowler, Mark J. Churcher, Li Jin, Len C. Packman, Adam Shlien, Peter Campbell, Michael Kirwan, Inderjeet Dokal, Alan J. Warren

Blood (2013) 121 (6): 1028–1038.

https://doi.org/10.1182/blood-2012-10-461491

Published: 2013

Includes: Supplemental data

Journal Articles

Clonal Analysis of SF3B1 , JAK2 and MPL in Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis

Ilaria Ambaglio, Anna Gallì, Daniela Pietra, Matteo G Della Porta, Marta Ubezio, Matteo C Da Vià, Elisa Bono, Chiara Milanesi, Erica Travaglino, Rosangela Invernizzi, Elli Papaemmanuil, Peter Campbell, Luca Malcovati, Mario Cazzola

Blood (2012) 120 (21): 172.

https://doi.org/10.1182/blood.V120.21.172.172

Published: 2012

Journal Articles

Composite Single Cell Genetics and Clonal Phylogeny in Acute Lymphoblastic Leukaemia

Nicola E Potter, PhD, Luca Ermini, PhD, Elli Papaemmanuil, Gowri Vijayaraghavan, Ian Titley, PhD, Giovanni Cazzaniga, PhD, Anthony M Ford, PhD, Lyndal Kearney, PhD, Peter Campbell, Mel Greaves, MD, PhD

Blood (2012) 120 (21): 122.

https://doi.org/10.1182/blood.V120.21.122.122

Published: 2012

Journal Articles

Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia Abrogate an Ubiquitination Site and Dysregulate SETBP1 Protein Levels

Blood (2012) 120 (21): LBA-2.

https://doi.org/10.1182/blood.V120.21.LBA-2.LBA-2

Published: 2012

Journal Articles

High Throughput Targeted Gene Sequencing in 738 Myelodysplastic Syndromes Patients Reveals Novel Oncogenic Genes, Rare Driver Mutations and Complex Molecular Signatures with Potential Impact for Patient Diagnosis and Prognosis in the Clinic

Elli Papaemmanuil, PhD, Moritz Gerstung, PhD, Luca Malcovati, MD, Sudhir Tauro, PhD, Gunes Gundem, PhD, Peter Van Loo, PhD, Andrea Pellagatti, PhD, Michael J Groves, PhD, Nick C.P. Cross, PhD, Carlo Gambacorti-Passerini, MD, Anthony R Green, MD, Jacqueline Boultwood, PhD, Paresh Vyas, MD, Eva Hellstrom-Lindberg, MD, David Bowen, MD, Mario Cazzola, MD, Michael R Stratton, MD, PhD, Peter Campbell, MD Phd

Blood (2012) 120 (21): LBA-5.

https://doi.org/10.1182/blood.V120.21.LBA-5.LBA-5

Published: 2012

Journal Articles

The Genomic Landscape of TEL-AML1 + ( ETV6-RUNX1 ) Acute Lymphoblastic Leukaemia

Elli Papaemmanuil, Inmaculada Rapado, Anthony M Ford, Keiran Raine, Jonathan Hinton, David Jones, John Marshall, Laura J Mudie, Jan Zuna, Giovanni Cazzaniga, Helena Kempski, Maria S Pombo de Oliveira, Mike R Stratton, P Andrew Futreal, Peter Campbell, Mel Greaves

Blood (2011) 118 (21): 403.

https://doi.org/10.1182/blood.V118.21.403.403

Published: 2011

Journal Articles

Whole Genome Sequencing Defines the Clonal Architecture and Genomic Evolution in Myeloma: Tumor Heterogeneity with Continued Acquisition of New Mutational Change

Nikhil C. Munshi, MD, Hervé Avet-Loiseau, MD, PhD, Philip J. Stephens, Graham R Bignell, Yu-Tzu Tai, PhD, Masood Shammas, Ph.D, Cheng Li, PhD, Parantu K Shah, PhD, Mariateresa Fulciniti, PhD, Jagannath Pal, PhD, Ankit V Vahia, Ph.D, Paul G. Richardson, MD, Stephane Minvielle, PhD, Peter Campbell, Kenneth C. Anderson, MD, Andrew Futreal

Blood (2011) 118 (21): 297.

https://doi.org/10.1182/blood.V118.21.297.297

Published: 2011

Journal Articles

Gene Mutations Detected by Whole-Exome Sequencing and Recurrent Cytogenetic Abnormalities Are Independent Events in Multiple Myeloma

Hervè Avet-Loiseau, MD, PhD, Graham R Bignell, Cheng Li, PhD, Florence Magrangeas, PhD, Thierry Facon, MD, Michel Attal, MD, Kenneth C. Anderson, MD, Peter Campbell, Stephane Minvielle, PhD, Nikhil C. Munshi, MD, Andrew Futreal

Blood (2011) 118 (21): 1816.

https://doi.org/10.1182/blood.V118.21.1816.1816

Published: 2011

Journal Articles

Increased basal intracellular signaling patterns do not correlate with JAK2 genotype in human myeloproliferative neoplasms

Shubha Anand, Frances Stedham, Emma Gudgin, Peter Campbell, Philip Beer, Anthony R. Green, Brian J. P. Huntly

Blood (2011) 118 (6): 1610–1621.

https://doi.org/10.1182/blood-2011-02-335042

Published: 2011

Includes: Supplemental data

Journal Articles

The JAK2 46/1 Haplotype Predisposes to Myeloproliferative Neoplasms Characterized by Diverse Mutations.

Nicholas C.P. Cross, PhD, FRCPath, Peter Campbell, MD, PhD, Philip A Beer, BM, MRCP, MRCPath, Susanne Schnittger, PhD, Alessandro M. Vannucchi, MD, Katerina Zoi, PhD, Melanie Percy, PhD, FRCPath, Mary Frances McMullin, Linda Scott, BSc, PhD, Richard T. Silver, MD, David Oscier, MD, Claire Harrison, MD, Anthony R. Green, FRCP, FRCPath, FMed, Sci, Andrew Chase, PhD

Blood (2009) 114 (22): 433.

https://doi.org/10.1182/blood.V114.22.433.433

Published: 2009

Journal Articles

Whole Genome Paired End Sequencing Identifies Genomic Evolution in Myeloma.

Nikhil C. Munshi, Herve Avet-Loiseau, MD, PhD, Phil Stephens, PhD, Masood A Shammas, PhD, Cheng Li, Ph.D, Leutz Buon, PhD, Samir B Amin, MBBS, Parantu Shah, PhD, Benjamin King, MD, Mariateresa Fulciniti, PhD, Jagannath Pal, MBBS, PhD, Yu-Tzu Tai, PhD, Paul Richardson, M.D., Ph.D., Stephane Minvielle, Ph.D, Peter Campbell, MD, Kenneth C. Anderson, MD, Andrew Futreal, PhD

Blood (2009) 114 (22): 2846.

https://doi.org/10.1182/blood.V114.22.2846.2846

Published: 2009

Journal Articles

Clinical Significance of MPL Mutations in Essential Thrombocythemia: Analysis of the PT-1 Cohort.

Philip Beer, Peter Campbell, Wendy Erber, Linda Scott, Anthony Bench, David Bareford, Wilkins Bridget, Keith Wheatley, Georgina Buck, Claire Harrison, Anthony Green

Blood (2007) 110 (11): 677.

https://doi.org/10.1182/blood.V110.11.677.677

Published: 2007

NARROW

Mutagenic DNA Lesions in Normal Hematopoietic Stem Cells Persist for Years Causing Distinct Patterns of Mutation

Pervasive Positive Selection in Blood in 200,618 Individuals and Novel Drivers of Clonal Hematopoiesis

Minimal Residual Disease Eradication with Venetoclax in Acute Myeloid Leukemia

Cohesin-dependent regulation of gene expression during differentiation is lost in cohesin-mutated myeloid malignancies

A Knowledge-Based Approach for Clinical Annotation of Oncogenic Variants to Support Patient-Tailored Diagnosis in Myeloid Disease

Analysis of Mutational Signatures Suggest That Aid Has an Early and Driver Role in Multiple Myeloma

Whole Genome Sequencing of Unique Paired SMM/MGUS Progressing to MM Samples Reveals a Genomic Landscape with Diverse Evolutionary Pattern

GATA1 -mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia

Aberrant 3′ oligoadenylation of spliceosomal U6 small nuclear RNA in poikiloderma with neutropenia

Clonal Analysis of SF3B1 , JAK2 and MPL in Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis

Composite Single Cell Genetics and Clonal Phylogeny in Acute Lymphoblastic Leukaemia

Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia Abrogate an Ubiquitination Site and Dysregulate SETBP1 Protein Levels

High Throughput Targeted Gene Sequencing in 738 Myelodysplastic Syndromes Patients Reveals Novel Oncogenic Genes, Rare Driver Mutations and Complex Molecular Signatures with Potential Impact for Patient Diagnosis and Prognosis in the Clinic

The Genomic Landscape of TEL-AML1 + ( ETV6-RUNX1 ) Acute Lymphoblastic Leukaemia

Whole Genome Sequencing Defines the Clonal Architecture and Genomic Evolution in Myeloma: Tumor Heterogeneity with Continued Acquisition of New Mutational Change

Gene Mutations Detected by Whole-Exome Sequencing and Recurrent Cytogenetic Abnormalities Are Independent Events in Multiple Myeloma

Increased basal intracellular signaling patterns do not correlate with JAK2 genotype in human myeloproliferative neoplasms

The JAK2 46/1 Haplotype Predisposes to Myeloproliferative Neoplasms Characterized by Diverse Mutations.

Whole Genome Paired End Sequencing Identifies Genomic Evolution in Myeloma.

Clinical Significance of MPL Mutations in Essential Thrombocythemia: Analysis of the PT-1 Cohort.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only